Solid beverage having assisted blood glucose lowering function, and preparation method thereof

Abstract

The invention relates to a solid beverage having an assisted blood glucose lowering function, and a preparation method thereof, wherein the main function components are three or more than three materials selected from kelp or a kelp extract, potassium alginate (low molecular weight potassium alginate), common yam rhizome or a common yam rhizome extract, Chinese wolfberry or a Chinese wolfberry extract, radix puerariae or a radix puerariae extract, mulberry leaf or a mulberry leaf extract, a polygonatum odoratum extract, a bitter gourd extract, the leaf of cyclocarya paliurus and corn stigma, the auxiliary materials comprise one or more than one materials selected from inulin, resistant dextrin, bean powder, tea powder, pumpkin powder, soybean protein powder, barley leaf powder, oat fiber powder, konjac powder and citrus fiber powder, and the flavoring agent is one or a plurality of materials selected from stevioside, xylitol, fructo oligosaccharide, isomaltitol, sucralose, trehalose, matcha powder, and fruit and vegetable powder. The preparation method comprises: 1, crushing, and screening; 2, weighing; 3, carrying out mixing stirring, or carrying out stirring mixing and granulation; and 4, packaging. The solid beverage of the present invention has advantages of significant blood glucose lowering effect, good safety, and no side effect.

Description

technical field [0001] The invention relates to the field of solid beverages, in particular to an auxiliary hypoglycemic solid beverage using seaweed extract and potassium alginate as raw materials and a preparation method thereof. Background technique [0002] Diabetes is a chronic non-infectious endocrine metabolic disease. Its etiology is that the body cannot produce insulin or the body develops resistance to insulin. Patients generally manifest as polydipsia, polyphagia, polyuria, weight loss, blood sugar and urine sugar levels. Increased, accompanied by fat and protein metabolism disorders, prone to vascular disease, ketoacidosis, a serious threat to the health of patients. Diabetes is divided into two types, one is type 1 diabetes, which is an autoimmune disease, which may be caused by the immune system destroying the beta cells of the pancreatic islets that produce insulin; the other is type 2 diabetes, which is mainly characterized by insulin resistance and relativel...

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment of diabetes mainly adopts a combination of drug therapy and non-drug therapy. The drugs for treating diabetes mainly include insulin, sulfonylurea, biguanide, α-glucosidase inhibitor, and new insulin sensitizers. Promote insulin secretion, reduce liver glycogen output or increase insulin sensitivity. Although these drugs can effectively control blood sugar, they have no ideal control effect on chronic complications of diabetes, and may easily cause hypoglycemia or lactic acidosis. Prevent the further necrosis of islet β cells, leading to different degrees of side effects such as further insulin dependence

Images